Clinical Trial Update: GnRH Agonist as Luteal Support in FET Cycles [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating GnRH agonist as luteal support in frozen embryo transfer cycles has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)

Snippet

Sponsor: Turku University Hospital | Conditions: Infertility | Phase 4 | Status: COMPLETED